Abstract: This paper presents the bias-policy iteration, a modified adaptive dynamic programming method, to achieve optimal control design of discrete-time nonlinear systems. Firstly, the formulation ...
Abstract: In this article, we employ a policy iteration reinforcement learning (RL) method to study continuous-time linear–quadratic mean-field control problems in infinite horizon. The drift and ...
With a stock price of $3.32, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the 10 Unrivaled Penny Stocks to Buy Now. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) reported first-quarter ...
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...
Good morning, everyone, and thank you for joining us. Since stepping into this role, I've been focused on a singular question: how do we harness the full power of AI to consistently and with urgency ...
Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...
SALT LAKE CITY, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and ...
Darío Gil, former SVP of IBM Research, is seen during the inauguration of Europe's first IBM Quantum Data Center on Oct. 1, 2024 in Ehningen, Germany. The tech industry veteran now serves as the ...
Hi, everyone. Let's get started. Welcome to the 44th Annual JPMorgan Healthcare Conference. My name is Priyanka Grover, and I'm part of the JPMorgan Biotech team. Today, our next presenting company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results